© 2002 by Oxford University Press
Journal of the National Cancer Institute, Vol. 94, No. 20, 1583-1584,
October 16, 2002
© 2002 Oxford University Press
CORRESPONDENCE |
RESPONSE: Re: Pretest Prediction of BRCA1 or BRCA2 Mutation by Risk Counselors and the Computer Model BRCAPRO
Affiliations of authors: D. M. Euhus, G. Tomlinson, The University of Texas Southwestern Medical Center at Dallas; L. Esserman, The University of California, San Francisco; P. A. Ganz, University of California Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, G. B. Mills, The University of Texas M. D. Anderson Cancer Center, Houston.
Correspondence to: David. M. Euhus, M.D., Division of Surgical Oncology, E6.222, U.T. Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 753909155 (e-mail: david.euhus@UTSouthwestern.edu).
| The first 10% of the full text of this article appears below. |
The data that Bonadona et al. present in their letter illustrates an important aspect of disease probability prediction that cannot be overemphasized: the predictive value of a test (e.g., the BRCAPRO computer model or the subjective estimate of a risk counselor) is related not only to the sensitivity and specificity of the test but also to the prevalence of